Abbott Laboratories Price to Free Cash Flow Ratio 2010-2024 | ABT

Abbott Laboratories current price to free cash flow ratio as of January 31, 2025 is 34.72.

  • Abbott Laboratories average price to free cash flow ratio for 2024 was 34.06, a 2.19% increase from 2023.
  • Abbott Laboratories average price to free cash flow ratio for 2023 was 33.33, a 49.19% increase from 2022.
  • Abbott Laboratories average price to free cash flow ratio for 2022 was 22.34, a 8.56% increase from 2021.

Price to free cash flow ratio can be defined as

Abbott Laboratories Price to Free Cash Flow Ratio 2010-2024 | ABT

  • Abbott Laboratories average price to free cash flow ratio for 2024 was 34.06, a 2.19% increase from 2023.
  • Abbott Laboratories average price to free cash flow ratio for 2023 was 33.33, a 49.19% increase from 2022.
  • Abbott Laboratories average price to free cash flow ratio for 2022 was 22.34, a 8.56% increase from 2021.

Price to free cash flow ratio can be defined as

Related Stocks
Company NameMarket
Cap
Boston Scientific (BSX)$151.4B
Stryker (SYK)$149.1B
EssilorLuxottica (ESLOY)$125.1B
Medtronic (MDT)$117.2B
Lonza Group Ag (LZAGY)$46B
Haleon (HLN)$43.1B
GE HealthCare Technologies (GEHC)$40.1B
ResMed (RMD)$37.1B
Terumo (TRUMY)$28.9B
Koninklijke Philips (PHG)$25.6B
Zimmer Biomet Holdings (ZBH)$22.1B
Insulet (PODD)$19.4B
Baxter (BAX)$16.7B
Smith & Nephew SNATS (SNN)$11.1B
BellRing Brands (BRBR)$10.1B
Sunny Optical Technology (SNPTF)$10B
Bio-Rad Laboratories (BIO)$10B
Demant (WILYY)$8.7B
Lantheus Holdings (LNTH)$6.4B
ICU Medical (ICUI)$4.1B
Prestige Consumer Healthcare (PBH)$3.9B
Envista Holdings (NVST)$3.7B
Haemonetics (HAE)$3.4B
Perrigo (PRGO)$3.4B
GN Store Nord (GNNDY)$3B
Shandong Weigao Medical Polymer (SHWGF)$3B
QuidelOrtho (QDEL)$2.9B
Neogen (NEOG)$2.5B
LeMaitre Vascular (LMAT)$2.2B
AtriCure (ATRC)$2.1B